Assessment of Similarity in Antipsychotic Exposure‐Response Relationships in Clinical Trials Between Adults and Adolescents With Acute Exacerbation of Schizophrenia-Reference-Cited by-同舟云学术

Assessment of Similarity in Antipsychotic Exposure‐Response Relationships in Clinical Trials Between Adults and Adolescents With Acute Exacerbation of Schizophrenia

Published:2020-01-28 Issue:7 Volume:60 Page:848-859
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Kalaria Shamir N.¹^ORCID,Farchione Tiffany R.²,Mathis Mitchell V.²,Gopalakrishnan Mathangi¹,Younis Islam²,Uppoor Ramana³,Mehta Mehul³,Wang Yaning³,Zhu Hao³

Affiliation:

1. Center for Translational MedicineUniversity of Maryland School of Pharmacy Baltimore Maryland USA

2. Division of Psychiatry ProductsOffice of New DrugsCenter for Drug Evaluation and ResearchUS Food and Drug Administration White Oak Maryland USA

3. Office of Clinical PharmacologyOffice of Translational ScienceCenter for Drug Evaluation and ResearchUS Food and Drug Administration White Oak Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1580

Reference37 articles.

1. Neurobiology and phenotypic expression in early onset schizophrenia

2. National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

3. Treatment of Early Onset Schizophrenia: Recent Trends, Challenges and Future Considerations

4. Treatment of adolescents with early-onset schizophrenia spectrum disorders

5. Schizophrenia in children and adolescents

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure–Response Modeling in Adults and Adolescents With Schizophrenia to Support the Extrapolation of Brexpiprazole Efficacy to Adolescents;The Journal of Clinical Pharmacology;2024-07-08

2. Pediatric Extrapolation Approach for U.S. Food and Drug Administration Approval of Brexpiprazole in Patients Aged 13 to 17 Years with Schizophrenia;The Journal of Clinical Pharmacology;2024-03-15

3. Regulatory considerations in the design and conduct of pediatric clinical trials;Essentials of Translational Pediatric Drug Development;2024

4. Population Pharmacokinetic Analysis of Brexpiprazole to Support its Indication and Dose Selection in Adolescents With Schizophrenia;The Journal of Clinical Pharmacology;2023-08

5. Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia;Journal of Child and Adolescent Psychopharmacology;2022-10-01